Antegrade dissection and re-entry vs retrograde strategy in chronic total occlusion percutaneous coronary

Maksymilian P Opolski1, Mateusz Spiewak2, Filip Machaj3

  • 1Department of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland.

Insights

The ADRENALINE trial compares antegrade dissection and re-entry (ADR) versus retrograde strategies for difficult chronic total occlusion percutaneous coronary intervention. It assesses procedural success, time, and patient outcomes in complex coronary interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Background:

  • Antegrade wiring (AW) is standard for chronic total occlusion (CTO) percutaneous coronary intervention (PCI).
  • Difficult CTO lesions often necessitate antegrade dissection and re-entry (ADR) or retrograde strategies.
  • Limited comparative data exists between ADR and retrograde approaches for complex CTO PCI.

Purpose of the Study:

  • To compare the efficacy and safety of ADR versus retrograde strategies in patients with difficult coronary CTO.
  • To evaluate procedural outcomes, including guidewire crossing success and procedure time.
  • To assess myocardial infarction and quality of life post-intervention.

Main Methods:

  • The ADRENALINE study is a prospective, multicenter randomized trial.
  • 121 patients with difficult CTO (J-CTO score ≥2) are planned for enrollment.
  • Patients with failed/unattempted AW are randomized 1:1 to ADR or retrograde strategies.

Main Results:

  • Co-primary endpoints include total procedure time and successful guidewire crossing.
  • Secondary assessments involve cardiac troponin T, creatine kinase-MB, and cardiac magnetic resonance (CMR).
  • Health status is evaluated using the Seattle Angina Questionnaire and Rose Dyspnea Scale.

Conclusions:

  • ADRENALINE is the first randomized study comparing ADR and retrograde strategies for difficult CTO PCI.
  • It will provide crucial data on procedural outcomes, CMR-detected myocardial infarction, and quality of life.
  • Findings will inform optimal treatment strategies for complex coronary interventions.
Abstract